NBW Capital LLC trimmed its position in shares of STERIS plc (NYSE:STE – Free Report) by 0.5% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 26,728 shares of the medical equipment provider’s stock after selling 131 shares during the quarter. NBW Capital LLC’s holdings in STERIS were worth $5,876,000 at the end of the most recent reporting period.
Other institutional investors also recently modified their holdings of the company. Millburn Ridgefield Corp acquired a new position in shares of STERIS during the third quarter worth approximately $25,000. Catalyst Capital Advisors LLC acquired a new position in shares of STERIS during the third quarter worth approximately $25,000. 1832 Asset Management L.P. acquired a new position in shares of STERIS during the first quarter worth approximately $25,000. Global Wealth Management Investment Advisory Inc. acquired a new position in shares of STERIS during the third quarter worth approximately $49,000. Finally, NBC Securities Inc. acquired a new position in shares of STERIS during the third quarter worth approximately $50,000. 94.69% of the stock is owned by institutional investors and hedge funds.
STERIS Stock Performance
NYSE:STE traded up $0.13 during trading on Thursday, reaching $200.37. The company’s stock had a trading volume of 270,857 shares, compared to its average volume of 457,358. The firm has a market cap of $19.80 billion, a price-to-earnings ratio of 35.07 and a beta of 0.79. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.49 and a current ratio of 2.43. The firm has a 50 day moving average of $224.59 and a 200-day moving average of $217.71. STERIS plc has a 12 month low of $180.54 and a 12 month high of $254.00.
STERIS Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, March 22nd. Stockholders of record on Friday, February 23rd were paid a dividend of $0.52 per share. The ex-dividend date of this dividend was Thursday, February 22nd. This represents a $2.08 annualized dividend and a dividend yield of 1.04%. STERIS’s payout ratio is 36.43%.
Wall Street Analysts Forecast Growth
STE has been the subject of several recent research reports. KeyCorp initiated coverage on STERIS in a report on Tuesday, February 6th. They set an “overweight” rating and a $253.00 price target for the company. Stephens reiterated an “overweight” rating and set a $250.00 price target on shares of STERIS in a report on Friday, February 9th. JMP Securities reiterated a “market outperform” rating and set a $265.00 price target on shares of STERIS in a report on Thursday, February 8th. Needham & Company LLC reiterated a “hold” rating on shares of STERIS in a report on Friday, April 12th. Finally, TheStreet upgraded STERIS from a “c+” rating to a “b” rating in a report on Wednesday, February 7th. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, STERIS has an average rating of “Moderate Buy” and an average target price of $239.60.
Get Our Latest Stock Report on STERIS
STERIS Company Profile
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
Further Reading
- Five stocks we like better than STERIS
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Comprehensive PepsiCo Stock Analysis
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- Golden Cross Stocks: Pattern, Examples and Charts
- Bear Market Funds to Watch This Year
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STE – Free Report).
Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.